Biomedical Research Goes Viral: Dangers and Opportunities.

Clicks: 364
ID: 106824
2020
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #28 of 72 articles by views in Cell

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Researchers around the globe have been mounting, accelerating, and redeploying efforts across disciplines and organizations to tackle the SARS-CoV-2 outbreak. However, humankind continues to be afflicted by numerous other devastating diseases in increasing numbers. Here, we outline considerations and opportunities toward striking a good balance between maintaining and redefining research priorities.
Reference Key
zeggini2020biomedicalcell Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Eleftheria Zeggini, Michael Baumann, Magdalena Götz, Stephan Herzig, Martin Hrabe de Angelis, Matthias H Tschöp
Are you one of these authors? Claim your profile
Journal Cell
Year 2020
DOI
S0092-8674(20)30576-6
URL
Keywords
Cancer proteasome neurodegeneration sars-cov-2 proteasome inhibitors

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.